| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.095 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.36 | 0.03 |